Fosaprepitant
- Product NDC
- 60505-6105
- 11-digit product format
- 605056105
- Labeler code
- 60505
- Product ID
- 60505-6105_8dee110c-65fa-1fb8-d0be-a7294591d982
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Fosaprepitant
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Apotex Corp
- Application
- ANDA205020
- Marketing category
- ANDA
- Marketing start
- 2019-09-05
- Marketing end
- 2023-11-30
- Substance
- FOSAPREPITANT DIMEGLUMINE
- Active strength
- 150 mg/5mL
- Pharmacologic classes
- Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Neurokinin 1 Antagonists [MoA], Substance P/Neurokinin-1 Receptor Antagonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 60505-6105-1 | 60505610501 | 1 VIAL, SINGLE-DOSE in 1 CARTON (60505-6105-1) > 5 mL in 1 VIAL, SINGLE-DOSE | 2019-09-05 | 0000-00-00 | No | No | Current |